The final report of the Special Commission on the Public Health and Safety Concerns Posed by the Proliferation of Xylazine as an Additive to Illicit Drugs, Including, but not limited to, Fentanyl (under Chapter 285 of the Acts of 2024, as amended by Section 95 of Chapter 14 of the Acts of 2025) on recommendations on ways to address the matter

This bill establishes a special commission to investigate the public health and safety risks associated with xylazine being mixed with illicit drugs like fentanyl. The commission will review current data and propose specific strategies to address the growing problem of xylazine use in Massachusetts. The findings and recommendations from this study will be compiled into a final report for legislative consideration. The primary focus is on creating actionable solutions to mitigate the dangers posed by this drug additive.